PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17652182-7	2007	N-Methylsulphonyl-6-(2-proparglyloxy-phenyl)hexanamide (MS-PPOH), a specific inhibitor of EET biosynthesis, significantly reduced I(to,peak) and increased APD in CYP2J2 Tr cardiomyocytes but not in Wt cells.	N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide	56-63	cytochrome P450 family 2 subfamily J member 2	Homo sapiens	162-168	
28698302-1	2017	The mechanism-based inactivation of human CYP2J2 by three terminal acetylenic compounds: N-(methylsulfonyl)-6-(2-propargyloxyphenyl)hexanamide (MS), 17-octadecynoic acid (OD), and danazol (DZ) was investigated.	N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide	89-142	cytochrome P450 family 2 subfamily J member 2	Homo sapiens	42-48	
28698302-1	2017	The mechanism-based inactivation of human CYP2J2 by three terminal acetylenic compounds: N-(methylsulfonyl)-6-(2-propargyloxyphenyl)hexanamide (MS), 17-octadecynoic acid (OD), and danazol (DZ) was investigated.	N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide	144-146	cytochrome P450 family 2 subfamily J member 2	Homo sapiens	42-48	
17264956-9	2007	The cytochrome P450 (CYP450) inhibitor, miconazole, and the arachidonic acid epoxygenase inhibitor MS-PPOH inhibited thrombin-stimulated t-PA release, while 5,6-EET-methyl ester stimulated t-PA release.	N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide	99-106	cytochrome P450 family 2 subfamily J member 2	Homo sapiens	60-88